SU, C.; CHAI, H.; SEE, Y.; KUMAR, R. S. GLYCEMIC CONTROL AND BODY WEIGHT EFFECTS OF SGLT2 INHIBITORS (EMPAGLIFLOZIN 25 MG, EMPAGLIFLOZIN 12.5 MG AND DAPAGLIFLOZIN 10 MG) IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS: A SINGLE CENTRE STUDY. Journal of the ASEAN Federation of Endocrine Societies, [S. l.], v. 39, n. S1, p. 25, 2024. Disponível em: https://asean-endocrinejournal.org/index.php/JAFES/article/view/4457. Acesso em: 20 jul. 2024.